NO20044554L - Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener - Google Patents
Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidenerInfo
- Publication number
- NO20044554L NO20044554L NO20044554A NO20044554A NO20044554L NO 20044554 L NO20044554 L NO 20044554L NO 20044554 A NO20044554 A NO 20044554A NO 20044554 A NO20044554 A NO 20044554A NO 20044554 L NO20044554 L NO 20044554L
- Authority
- NO
- Norway
- Prior art keywords
- melagatran
- combination product
- oxabispidens
- antiarrhythmic
- compound
- Prior art date
Links
- 239000013066 combination product Substances 0.000 title abstract 2
- 229940127555 combination product Drugs 0.000 title abstract 2
- DKWNMCUOEDMMIN-PKOBYXMFSA-N melagatran Chemical compound C1=CC(C(=N)N)=CC=C1CNC(=O)[C@H]1N(C(=O)[C@H](NCC(O)=O)C2CCCCC2)CC1 DKWNMCUOEDMMIN-PKOBYXMFSA-N 0.000 title abstract 2
- 229960002137 melagatran Drugs 0.000 title abstract 2
- 230000003288 anthiarrhythmic effect Effects 0.000 title 1
- 239000003416 antiarrhythmic agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940126062 Compound A Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201373A SE0201373D0 (sv) | 2002-05-06 | 2002-05-06 | Combination therapy |
| PCT/SE2003/000720 WO2003092721A1 (en) | 2002-05-06 | 2003-05-05 | A combination product comprising melagatran and an anti-arrhythmic oxabispidenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044554L true NO20044554L (no) | 2004-11-16 |
Family
ID=20287788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044554A NO20044554L (no) | 2002-05-06 | 2004-10-22 | Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060074080A1 (is) |
| EP (1) | EP1503782A1 (is) |
| JP (1) | JP2005531546A (is) |
| KR (1) | KR20050007470A (is) |
| CN (1) | CN1652811A (is) |
| AR (1) | AR039572A1 (is) |
| AU (1) | AU2003224590A1 (is) |
| BR (1) | BR0309354A (is) |
| CA (1) | CA2483001A1 (is) |
| IL (1) | IL164869A0 (is) |
| IS (1) | IS7561A (is) |
| MX (1) | MXPA04010716A (is) |
| NO (1) | NO20044554L (is) |
| PL (1) | PL372368A1 (is) |
| RU (1) | RU2004129730A (is) |
| SE (1) | SE0201373D0 (is) |
| TW (1) | TW200403071A (is) |
| WO (1) | WO2003092721A1 (is) |
| ZA (1) | ZA200408615B (is) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
| US6462021B1 (en) * | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
-
2002
- 2002-05-06 SE SE0201373A patent/SE0201373D0/xx unknown
-
2003
- 2003-05-02 TW TW092112174A patent/TW200403071A/zh unknown
- 2003-05-05 WO PCT/SE2003/000720 patent/WO2003092721A1/en not_active Ceased
- 2003-05-05 EP EP03721266A patent/EP1503782A1/en not_active Withdrawn
- 2003-05-05 JP JP2004500904A patent/JP2005531546A/ja active Pending
- 2003-05-05 PL PL03372368A patent/PL372368A1/xx not_active Application Discontinuation
- 2003-05-05 MX MXPA04010716A patent/MXPA04010716A/es unknown
- 2003-05-05 RU RU2004129730/15A patent/RU2004129730A/ru not_active Application Discontinuation
- 2003-05-05 BR BR0309354-9A patent/BR0309354A/pt not_active IP Right Cessation
- 2003-05-05 KR KR10-2004-7017782A patent/KR20050007470A/ko not_active Withdrawn
- 2003-05-05 CN CNA038102129A patent/CN1652811A/zh active Pending
- 2003-05-05 CA CA002483001A patent/CA2483001A1/en not_active Abandoned
- 2003-05-05 AU AU2003224590A patent/AU2003224590A1/en not_active Abandoned
- 2003-05-05 US US10/513,187 patent/US20060074080A1/en not_active Abandoned
- 2003-05-06 AR ARP030101594A patent/AR039572A1/es unknown
-
2004
- 2004-10-22 NO NO20044554A patent/NO20044554L/no not_active Application Discontinuation
- 2004-10-25 ZA ZA200408615A patent/ZA200408615B/en unknown
- 2004-10-27 IL IL16486904A patent/IL164869A0/xx unknown
- 2004-11-29 IS IS7561A patent/IS7561A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003092721A1 (en) | 2003-11-13 |
| TW200403071A (en) | 2004-03-01 |
| PL372368A1 (en) | 2005-07-25 |
| JP2005531546A (ja) | 2005-10-20 |
| BR0309354A (pt) | 2005-02-15 |
| SE0201373D0 (sv) | 2002-05-06 |
| US20060074080A1 (en) | 2006-04-06 |
| ZA200408615B (en) | 2006-04-26 |
| IL164869A0 (en) | 2005-12-18 |
| RU2004129730A (ru) | 2005-07-10 |
| IS7561A (is) | 2004-11-29 |
| MXPA04010716A (es) | 2005-03-07 |
| KR20050007470A (ko) | 2005-01-18 |
| CA2483001A1 (en) | 2003-11-13 |
| CN1652811A (zh) | 2005-08-10 |
| AU2003224590A1 (en) | 2003-11-17 |
| AR039572A1 (es) | 2005-02-23 |
| EP1503782A1 (en) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| TW200505881A (en) | Tri(cyclo) substituted amide compounds | |
| GB9822450D0 (en) | Medicaments | |
| UA74346C2 (uk) | Похідні амінодикарбонових кислот, їх застосування та лікарський засіб | |
| WO2001066564A3 (en) | Gamma-secretase inhibitors | |
| GEP20043324B (en) | Purine Derivatives | |
| CA2420694A1 (en) | Guanidinobenzamides as mc4-r agonists | |
| EP1268412B8 (en) | Sulphonamido-substituted bridged bicycloalkyl derivatives | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| NO20054852L (no) | GFAT inhibitorer | |
| AU2002239830A1 (en) | Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof | |
| AU2003233010A8 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
| NO20060971L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| NO331024B1 (no) | Anvendelse av risendroninsyre for forebygging eller behandling av osteoporose | |
| MXPA03008215A (es) | Inhibidores de integrina alfa v beta 6. | |
| AU3850600A (en) | Dalda analogs and their use | |
| SI1546127T1 (sl) | Novi pirimidinamidni derivati in njihova uporaba | |
| DE602004011966D1 (en) | Heterocyclylverbindungen | |
| ATE402175T1 (de) | 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| NO20050662L (no) | COX-2 inhiberende pyridinderivater | |
| WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
| AU2003224747A1 (en) | Technetium-labeled rotenone derivatives, and methods of use thereof | |
| NO20016201L (no) | Tienopyrimidiner som fosfodiesteraseinhibitorer | |
| ATE451934T1 (de) | Pharmazeutische zusammensetzung zur behandlung von rhinitiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |